Version 2.5.2.0 CRISP Logo CRISP Homepage Help for CRISP Email Us

Abstract

Grant Number: 5R42NS046997-04
Project Title: Novel CSF biomarker to predict impaired cognition in HIV
PI Information:NameEmailTitle
GIULIAN, DANA dgiulian@bcm.tmc.edu PROFESSOR

Abstract: DESCRIPTION (provided by applicant): The focus of this project is to explore the relationship between inflammatory cells and cognitive dysfunction in populations with HIV-1 infection. Extensive work has found that a biomarker is detected in lumbar cerebrospinal fluid of HIV(+) subjects with impaired cognition. Presently there are no suitable clinical tests to identify early neuro-inflammatory injury to neurons in such disorders as HIV-1 dementia. The ability to identify and treat HIV(+) populations before the onset of irreversible brain damage is highly desirable and forms the basis for this STTR proposal.

Thesaurus Terms:
AIDS /HIV neuropathy, biomarker, cerebrospinal fluid, cognition disorder, diagnosis design /evaluation, neurotoxin, technology /technique development
AIDS dementia complex, cognition, diagnostic test, early diagnosis, health related legal, mental disorder diagnosis, nervous system disorder diagnosis, neural information processing, neuropathology, neuropsychological test, synapse, tissue /cell culture
clinical research, human subject, laboratory rat, patient oriented research

Institution: INFLAME THERAPEUTICS, INC.
8080 NORTH STADIUM DRIVE
HOUSTON, TX 77054
Fiscal Year: 2006
Department:
Project Start: 15-FEB-2004
Project End: 31-JUL-2008
ICD: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
IRG: ZRG1


CRISP Homepage Help for CRISP Email Us